Yale: Drug Slows Clinical Decline of Patients With Early-Stage Alzheimer's
January 06, 2023
January 06, 2023
NEW HAVEN, Connecticut, Jan. 6 (TNSjou) -- Yale University issued the following news:
* * *
An experimental dementia drug slowed clinical decline in people with early-stage Alzheimer's disease in a phase 3 clinical trial, a new study shows.
* * *
The investigational drug lecanemab slowed clinical decline in participants with early-stage Alzheimer's disease by 27% after 18 months of treatment compared with participants who received a p . . .
* * *
An experimental dementia drug slowed clinical decline in people with early-stage Alzheimer's disease in a phase 3 clinical trial, a new study shows.
* * *
The investigational drug lecanemab slowed clinical decline in participants with early-stage Alzheimer's disease by 27% after 18 months of treatment compared with participants who received a p . . .